Response to "Pervasive Sequence Patents Cover the Entire Human Genome"

Authors

Shine Tu, West Virginia University College of LawFollow
Christopher M. Holman, University of Missouri - Kansas City School of LawFollow
Adam Mossoff, George Mason University School of LawFollow
Ted M. Sichelman, University of San Diego School of LawFollow
Michael Risch, Villanova University School of LawFollow
Jorge L. Contreras, University of Utah - S.J. Quinney College of LawFollow
Yaniv Heled, Georgia State University College of LawFollow
Gregory Dolin, University of Baltimore School of LawFollow
Lee Petherbridge, Loyola Law School Los AngelesFollow

Document Type

Article

Publication Date

2014

Abstract

In a widely reported article by Jeffrey Rosenfeld and Christopher Mason published in Genome Medicine, significant misstatements were made, because the authors did not sufficiently review the claims – which define the legal scope of a patent – in the patents they analyzed. Specifically, the authors do not provide an adequate basis for their assertion that 41% of the genes in the human genome have been claimed.

Recommended Citation

Response to "Pervasive Sequence Patents Cover the Entire Human Genome," 6 Genome Med. 14 (2014) (co-authored)